We're sorry. This study is closed and no longer recruiting participants.
STUDY BASICS
Have you been told by a doctor that you may have nonalcoholic steatohepatitis (NASH)? If so, you may be able to participate in a study to evaluate the safety and effectiveness of an investigational new drug called Aramchol on NASH and NASH-related complications. This study involves 6 visits in year one and visits every four months until the end of the study. Reimbursement provided for visits.